In this article, we compare the requirements to obtain patents in the U.S. and Europe in the context of computer-implemented inventions such as simulation methods and artificial intelligence (AI).
Often, when the AI identifies a drug, and experiments confirm it is useful for the intended purpose, the drug can be patented. But what about the AI itself – can the AI be protected by patents, and should you try to?
Many of us are familiar with binge-watching TV series on Netflix, but few of us are familiar with Netflix’s vast intellectual property (IP) portfolio. We take a look at Netflix’s IP story in this article, which contains as many twists and turns as one of its original dramas.
In the present climate it is clear that there is enormous pressure on healthcare systems across the globe. Further, an increasingly aging population leads to a number of healthcare challenges including that people are living longer generally with one or more chronic conditions.
Many start-up companies are developing artificial intelligence (AI) innovations, from AI-driven drug discovery to AI-based fruit harvesting. Many of these companies protect their AI inventions by filing patent applications.
UK High Court decision confirms that an artificial intelligence machine cannot be named as an inventor.